258MO Niraparib plus abiraterone acetate plus prednisone (NIRA+AAP) as first-line treatment in patients with BRCA+ metastatic castration-resistant prostate cancer (mCRPC): Second i... von Saad, M., Chi, K.N., Sandhu, S.K., Attard, G., Ye, D., Li, L., Jung, W., Pang, S-T., Francis, P.S.J., Li, S., Dibaj, S., Zhang, J., Kim, W., Lopez-Gitlitz, A., Wu, D., Singh, A., De Vries, R., Zhang, L., Lee, J.Y.

Volltext

1835P A prospective study to determine the prevalence of DNA repair defects in patients (pts) with advanced prostate cancer (PC) von Sandhu, S.K., Gotto, G., Vera-Badillo, F.E., Byun, S-S., Cutuli, H.J., Gomes, A.J.P.D.S., Helissey, C., Karsh, L.I., Peer, A., Preto, D.D., Pu, Y-S., Ravilla, R., Roubaud, G., Skoneczna, I.A., Kim, W., Espina, B., Withelder, M., Urtishak, K., Francis, P.S.J., Saad, F.

Volltext